Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Kidney International Reports|November 13, 2024
Opportunities in Primary and Enteric Hyperoxaluria at the Cross-Roads Between the Clinic and LaboratoryBarbara Cellini, Michelle A Baum, Yaacov Frishberg, et al.
Kidney International Reports|July 31, 2024
Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1: Results from a Phase III Clinical TrialJeffrey M Saland, John C Lieske, Jaap W Groothoff, et al.
Human Mutation|February 10, 2017
Deficiency of the sphingosine-1-phosphate lyase SGPL1 is associated with congenital nephrotic syndrome and congenital adrenal calcificationsAndreas R Janecke, Ruijuan Xu, Elisabeth Steichen-Gersdorf, et al.
Kidney Medicine|November 10, 2025
Natural History of Advanced Primary Hyperoxaluria Type 1: A Retrospective StudyJohn C Lieske, Jaap W Groothoff, Yaacov Frishberg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 17, 2022
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C TrialMini Michael, Jaap W Groothoff, Hadas Shasha-Lavsky, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 14, 2021
Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical TrialYaacov Frishberg, Georges Deschênes, Jaap W Groothoff, et al.
Kidney International Reports|March 8, 2022
Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1Sally A Hulton, Jaap W Groothoff, Yaacov Frishberg, et al.
Kidney International Reports|October 18, 2023
Diagnostic Utility of Exome Sequencing Among Israeli Children With Kidney FailureYishay Ben-Moshe, Omer Shlomovitz, Danit Atias-Varon, et al.
The New England Journal of Medicine|March 31, 2021
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1Sander F Garrelfs, Yaacov Frishberg, Sally A Hulton, et al.
The Journal of Clinical Investigation|July 23, 2013
ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signalingHeon Yung Gee, Pawaree Saisawat, Shazia Ashraf, et al.
Pageof 7